Loeillot Olivier — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Loeillot Olivier has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.73M.

Profile

Olivier Loeillot is the Chief Executive Officer of Repligen Corporation, a leading global life sciences company specializing in bioprocessing equipment and supplies for the biopharmaceutical industry. He has been instrumental in driving the company's growth and innovation in the manufacturing of biologic drugs.

Board memberships

• Repligen Corporation

Awards & honors

• Led Repligen Corporation as CEO
• Contributed to growth in bioprocessing technology
• Oversaw product development in biologic drug manufacturing

Recent Transactions

Companies — Last 90 Days

• REPLIGEN CORP (RGEN) — 1 filings, last 2026-04-22

Frequently Asked Questions

Who is Loeillot Olivier?

Olivier Loeillot is the Chief Executive Officer of Repligen Corporation, a leading global life sciences company specializing in bioprocessing equipment and supplies for the biopharmaceutical industry. He has been instrumental in driving the company's growth and innovation in the manufacturing of biologic drugs.…

How many SEC Form 4 filings has Loeillot Olivier submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Loeillot Olivier been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.73M) across all tracked filings.

Where can I see all of Loeillot Olivier's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week